Tectonic Therapeutic Inc/$TECX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tectonic Therapeutic Inc
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Ticker
$TECX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
51
ISIN
US8789721086
Website
TECX Metrics
BasicAdvanced
$415M
-
-$4.72
-
-
Price and volume
Market cap
$415M
52-week high
$27.04
52-week low
$13.70
Average daily volume
204K
Financial strength
Current ratio
22.92
Quick ratio
22.668
Long term debt to equity
0.094
Total debt to equity
0.874
Interest coverage (TTM)
-659.84%
Management effectiveness
Return on assets (TTM)
-22.89%
Return on equity (TTM)
-41.59%
Valuation
Price to book
1.38
Price to tangible book (TTM)
1.38
Price to free cash flow (TTM)
-4.376
Growth
Earnings per share change (TTM)
-71.46%
TECX News
AllArticlesVideos
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
GlobeNewsWire·6 days ago
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewsWire·2 weeks ago
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF
Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tectonic Therapeutic Inc stock?
Tectonic Therapeutic Inc (TECX) has a market cap of $415M as of May 23, 2025.
What is the P/E ratio for Tectonic Therapeutic Inc stock?
The price to earnings (P/E) ratio for Tectonic Therapeutic Inc (TECX) stock is 0 as of May 23, 2025.
Does Tectonic Therapeutic Inc stock pay dividends?
No, Tectonic Therapeutic Inc (TECX) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Tectonic Therapeutic Inc dividend payment date?
Tectonic Therapeutic Inc (TECX) stock does not pay dividends to its shareholders.
What is the beta indicator for Tectonic Therapeutic Inc?
Tectonic Therapeutic Inc (TECX) does not currently have a Beta indicator.